Advertisement

Topics

The Croes•Oliva Group Company Profile

16:11 EST 13th December 2018 | BioPortfolio

The initial focus of The Croes•Oliva Group was to help physicians in private practice operate profitably in an increasingly demanding market.
During the early 90's, as healthcare reimbursement rates tumbled, competition for patients intensified. Physicians in private practice were the first to feel the pressure to simultaneously increase revenue and lower the cost of care delivery.
Using an innovative, multi-disciplined approach, The Croes•Oliva Group helped these private practices achieve what they had previously thought impossible: improved access and higher profits.
In the mid 90's, the pressure to deliver medical care more efficiently spread to community hospitals and integrated delivery systems. Looking to bolster their services through partnerships, these organizations began to buy physician practices, which they pushed and pulled in an effort to manage them profitably. When resistance was encountered, The Croes•Oliva Group was brought in to help. Through our efforts, community hospitals and integrated delivery systems found ways to make their new alliances more successful.
The late 90's brought academic medical centers into the fray. Faced with dwindling research and teaching dollars, these centers were now being pressured to provide clinical care on, at the very least, a break-even basis. Applying the lessons learned through successful physician practice management, The Croes•Oliva Group began helping academic medical centers reap greater revenue from clinical care without curtailing their commitments to research and teaching.

Location

111 South Bedford StreetSuite 101
Burlington
Massachusetts
01803
United States of America

Contact

Phone: (781) 272-5055
Email: joliva@cogrp.com


News Articles [664 Associated News Articles listed on BioPortfolio]

Zur Rose Group announces result of rights take-up

EQS Group-News: Zur Rose Group AG / Key word(s): Capital Increase 28.11.2018 / 17:35 Under the following link, you will find a press release of the Zur Rose Group.   https://zurrosegrou...

Zur Rose Group successfully concludes rights issue and announces offer price of CHF 93 per new share

EQS Group-News: Zur Rose Group AG / Key word(s): Capital Increase 29.11.2018 / 07:00 Under the following link, you will find a press release of the Zur Rose Group.   https://zurrosegrou...

Maricann Group Inc.: Mit Volldampf in die Zukunft! - CEO Ben Ward gibt Ausblick über hervorragende Entwicklung der Wayland Group

Dow Jones hat von EQS/DGAP eine Zahlung für die Verbreitung dieser Pressemitteilung über sein Netzwerk erhalten. DGAP-Media / 2018-11-21 / 10:42 *Unternehmen: Wayland Group (ehemals Maricann Group.....

Delek Group Announces Consolidated Second Quarter 2018 Results

TEL AVIV, Israel, Aug. 30, 2018 /PRNewswire/ -- Delek Group Ltd. (TASE: DLEKG) (OTC: DGRLY) (hereinafter: "Delek Group" or "The Group") announced today its results Read more...

#Cannabisstocks: Cronos Group (NASDAQ: $CRON) (TSX: $CRON.TO) Confirms Discussions Regarding Potential Investment by Altria Group (NYSE: $MO)

TORONTO - December 4, 2018 (Investorideas.com Newswire) Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company") confirmed that it is engaged in discussions concerning a potentia...

Maricann Group Inc.: Sensations Coup! Einstieg in argentinischen Cannabis Markt - Wayland Group erwirbt über 800 Hektar Anbaufläche!

Dow Jones hat von EQS/DGAP eine Zahlung für die Verbreitung dieser Pressemitteilung über sein Netzwerk erhalten. DGAP-Media / 2018-12-11 / 07:20 *Unternehmen: Wayland Group (ehemals Maricann Group.....

Capital increase of the Zur Rose Group: Further information on the rights issue

EQS Group-News: Zur Rose Group AG / Key word(s): Capital Increase 04.12.2018 / 07:00 Under the following link, you will find a press release of the Zur Rose Group.   https://zurrosegrou...

Capital increase of Zur Rose Group: Further information on the rights issue

EQS Group-News: Zur Rose Group AG / Key word(s): Capital Increase 03.12.2018 / 06:00 Under the following link, you will find a press release of the Zur Rose Group.   https://zurrosegrou...

PubMed Articles [1743 Associated PubMed Articles listed on BioPortfolio]

Does Timing of Surgery Affect Treatment of the Terrible Triad of the Elbow?

BACKGROUND This study investigated the influence of surgical timing on the treatment of terrible triad of the elbow (TTE). MATERIAL AND METHODS After exclusion, 63 patients were enrolled in this study...

Isolation and exploitation of minority: Game theoretical analysis.

We investigate various group-size distributions occurring in a situation where each group's resource is exposed to appropriation by other groups. The amount of appropriation depends on the size differ...

Group I introns are widespread in archaea.

Group I catalytic introns have been found in bacterial, viral, organellar, and some eukaryotic genomes, but not in archaea. All known archaeal introns are bulge-helix-bulge (BHB) introns, with the exc...

The role of group cohesion in a group-based behavioral weight loss intervention.

Behavioral weight loss interventions are often delivered in groups. Group cohesion may enhance program attendance and, thereby, weight loss. In this secondary analysis, our goals were to: (1a) assess ...

Experimental animal study of docetaxel combined with carboplatin in the treatment of retinoblastoma.

The synergistic effects of docetaxel (DTX) combined with carboplatin in the treatment of retinoblastoma (RB) was explored in mouse RB xenografts compared with carboplatin alone and DTX alone groups. R...

Clinical Trials [4112 Associated Clinical Trials listed on BioPortfolio]

Percutaneous Nephrolithotomy for Treatment of Kidney Stones Greater Than 2 cm

Percutaneous nephrolithotomy (PCNL) is a minimally invasive procedure considered as the treatment of choice for the management of large-scale and fully-formed kidney stones.This procedure ...

The Influence of Hypotensive Drugs on Mineral Status in Experimental and Clinical Studies

The aim of the study was to evaluate the effects of hypotensive treatment combined with a higher zinc supply in the diet and supplements on the mineral status and selected biochemical para...

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Ultrasound and Exercises in Knee Osteoarthritis

The aim of this investigation is to compare the effects of continuous (CUS) and pulsed (PUS) ultrasound associated with a program of exercises on pain, range of motion, muscle strength, fu...

Technical Development of Multi-Parametric Renocerebral MRI

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and ...

Companies [1641 Associated Companies listed on BioPortfolio]

The Croes•Oliva Group

The initial focus of The Croes•Oliva Group was to help physicians in private practice operate profitably in an increasingly demanding market. During the early 90's, as healthcare reimbursement rates...

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital ...

PharmEvo (Pvt.) Ltd.

PharmEvo is backed by a reputable corporate group with a history of successful business ventures spread over 30 years. The group made its debut in 1971, with the sales and marketing of prestigious bra...

ACE Group

Celebrating 25 years of insuring progress, the ACE Group is a global leader in insurance and reinsurance serving a diverse group of clients. Headed by ACE Limited (NYSE:ACE), a co...

Man Group plc

The Man Group has its origins over 200 years ago in a broking business founded by James Man and was floated on the London Stock Exchange in 1994. Man Group plc trades on the London Stock Exchange (EMG...

More Information about "The Croes•Oliva Group" on BioPortfolio

We have published hundreds of The Croes•Oliva Group news stories on BioPortfolio along with dozens of The Croes•Oliva Group Clinical Trials and PubMed Articles about The Croes•Oliva Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Croes•Oliva Group Companies in our database. You can also find out about relevant The Croes•Oliva Group Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record